Sort   by:  
 Page size 
UnknownOptimizing renal function and outcome of patients with cT2 renal cell carcinoma.
Not available
S-EPMC6462607 | biostudies-literature
UnknownAngiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma.
Not available
S-EPMC5122335 | biostudies-literature
UnknownSurvival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy.
Not available
S-EPMC10113474 | biostudies-literature
UnknownRole of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients.
Not available
S-EPMC3392267 | biostudies-literature
UnknownVEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib.
Not available
S-EPMC3619056 | biostudies-literature
UnknownAngiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients.
Not available
S-EPMC4846860 | biostudies-literature
UnknownImpact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience.
Not available
S-EPMC6873043 | biostudies-literature
UnknownRole of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin.
Not available
S-EPMC6470641 | biostudies-literature
UnknownBone metastases in biliary cancers: A multicenter retrospective survey.
Not available
S-EPMC6054714 | biostudies-literature
UnknownClustered protocadherins methylation alterations in cancer.
Not available
S-EPMC6617643 | biostudies-literature
Sort   by:  
 Page size